logo
Plus   Neg
Share
Email

Quest Diagnostics Continues To Post Steep Loss In Late-Day Trading

Shares of Quest Diagnostics Inc. (DGX) continue to see substantial weakness in late-day trading on Thursday after falling sharply early in the session. After hitting a two-year intraday low, Quest Diagnostics is currently down by 9.2 percent.

Quest Diagnostics initially came under pressure after the lab testing services provider lowered its full-year earnings and revenue forecast.

The company said it now expects full-year earnings greater than $6.30 per share on revenues of approximately $7.57 billion compared to its previous forecast for earnings of $6.53 to $6.60 per share on revenues of around $7.62 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

More Breaking News

1 Articles
Editors Pick
Luckin Coffee Inc., Starbucks Corp.'s biggest rival in China, filed for an Initial Public Offering in the U.S. In a filing with the Securities and Exchange Commission, the China-based coffee chain said it has applied for listing its American Depositary Shares or ADSs on the Nasdaq under the symbol "LK" and also set a placeholder amount of $100 million. Micro-blogging site Twitter Inc. (TWTR) Tuesday reported a surge in its first-quarter profit. Both earnings and revenues beat analysts' estimates, sending shares up by 6 percent in the pre-market trading. But, Twitter's average monthly active users or MAU figure declined from last year. Verizon Communications Inc. on Tuesday reported a nearly 11 percent increase in profit for the first quarter from last year on higher wireless revenues and flat expenses. Adjusted earnings per share for the quarter beat analysts' estimates, while revenues were in-line with expectations. Looking ahead, the company raised its adjusted earnings outlook for fiscal 2019.
Follow RTT